$5.23 Billion is the total value of Matrix Capital Management Company, LP's 26 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 50.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
Buy | GLOBALFOUNDRIES INCordinary shares | $842,656,000 | +65.9% | 17,428,260 | +38.4% | 16.12% | +40.0% | |
TDG | TRANSDIGM GROUP INC | $574,625,000 | -2.2% | 1,094,900 | 0.0% | 10.99% | -17.5% | |
CRWD | CROWDSTRIKE HLDGS INCcl a | $494,430,000 | -2.2% | 3,000,000 | 0.0% | 9.46% | -17.5% | |
ALTR | Buy | ALTAIR ENGR INC | $455,687,000 | -6.7% | 10,305,000 | +10.8% | 8.72% | -21.2% |
AMZN | New | AMAZON COM INC | $452,565,000 | – | 4,005,000 | +100.0% | 8.66% | – |
TWLO | Buy | TWILIO INCcl a | $386,406,000 | +55.4% | 5,588,749 | +88.3% | 7.39% | +31.1% |
QCOM | QUALCOMM INC | $377,055,000 | -11.6% | 3,337,360 | 0.0% | 7.21% | -25.3% | |
AMAT | Buy | APPLIED MATLS INC | $316,496,000 | +8.3% | 3,863,000 | +20.2% | 6.05% | -8.6% |
NVDA | New | NVIDIA CORPORATION | $218,502,000 | – | 1,800,000 | +100.0% | 4.18% | – |
MU | MICRON TECHNOLOGY INC | $200,400,000 | -9.4% | 4,000,000 | 0.0% | 3.83% | -23.5% | |
ZNTL | ZENTALIS PHARMACEUTICALS INC | $199,271,000 | -22.9% | 9,199,973 | 0.0% | 3.81% | -34.9% | |
WDAY | WORKDAY INCcl a | $170,645,000 | +9.1% | 1,121,043 | 0.0% | 3.26% | -8.0% | |
ASML | New | ASML HOLDING N V | $129,755,000 | – | 312,400 | +100.0% | 2.48% | – |
ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $82,397,000 | -12.0% | 11,572,590 | 0.0% | 1.58% | -25.7% | |
AURA BIOSCIENCES INC | $74,525,000 | +27.9% | 4,112,870 | 0.0% | 1.43% | +7.9% | ||
ZS | New | ZSCALER INC | $62,263,000 | – | 378,800 | +100.0% | 1.19% | – |
PERIMETER SOLUTIONS SA | $59,775,000 | -26.1% | 7,462,500 | 0.0% | 1.14% | -37.6% | ||
CRM | SALESFORCE INC | $45,525,000 | -12.8% | 316,500 | 0.0% | 0.87% | -26.4% | |
ADAP | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $41,897,000 | -36.8% | 38,974,185 | 0.0% | 0.80% | -46.7% | |
VENTYX BIOSCIENCES INC | $11,695,000 | +185.5% | 335,000 | 0.0% | 0.22% | +140.9% | ||
NET | New | CLOUDFLARE INC | $8,850,000 | – | 160,000 | +100.0% | 0.17% | – |
U | New | UNITY SOFTWARE INC | $8,220,000 | – | 258,000 | +100.0% | 0.16% | – |
IMAGO BIOSCIENCES INC | $5,433,000 | +12.4% | 361,000 | 0.0% | 0.10% | -5.5% | ||
ZI | New | ZOOMINFO TECHNOLOGIES INC | $4,833,000 | – | 116,000 | +100.0% | 0.09% | – |
ADCT | ADC THERAPEUTICS SA | $1,928,000 | -39.4% | 400,000 | 0.0% | 0.04% | -48.6% | |
TXG | New | 10X GENOMICS INC | $1,709,000 | – | 60,000 | +100.0% | 0.03% | – |
Exit | WOLFSPEED INC | $0 | – | -100,000 | -100.0% | -0.14% | – | |
NFLX | Exit | NETFLIX INC | $0 | – | -2,000,000 | -100.0% | -7.93% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
TRANSDIGM GROUP INC | 42 | Q3 2023 | 13.3% |
WORKDAY INC | 42 | Q3 2023 | 19.7% |
NETFLIX INC | 37 | Q2 2022 | 26.1% |
NEW RELIC INC | 29 | Q1 2022 | 7.8% |
DAVITA INC | 26 | Q3 2019 | 6.1% |
ADAPTIMMUNE THERAPEUTICS PLC | 26 | Q3 2023 | 6.8% |
SALESFORCE INC | 23 | Q3 2022 | 18.4% |
CONSTELLATION BRANDS INC | 23 | Q2 2019 | 5.7% |
AMAZON COM INC | 21 | Q3 2023 | 11.2% |
TABLEAU SOFTWARE INC | 20 | Q2 2019 | 15.2% |
View Matrix Capital Management Company, LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Adaptimmune Therapeutics PLC | July 10, 2023 | 233,845,110 | 17.3% |
Zentalis Pharmaceuticals, Inc. | June 20, 2023 | 13,959,973 | 19.8% |
ForgeRock, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
NEW RELIC, INC.Sold out | February 13, 2023 | 0 | 0.0% |
Perimeter Solutions, SA | February 13, 2023 | 8,587,500 | 5.4% |
Aura Biosciences, Inc. | December 07, 2022 | 5,362,870 | 14.5% |
Adaptive Biotechnologies Corp | February 14, 2022 | 11,572,590 | 8.2% |
BigCommerce Holdings, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
CarGurus, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
Trillium Therapeutics Inc.Sold out | February 14, 2020 | 0 | 0.0% |
View Matrix Capital Management Company, LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-13 |
SC 13G/A | 2024-02-13 |
13F-HR | 2023-11-14 |
4 | 2023-11-09 |
SC 13D/A | 2023-11-09 |
13F-HR | 2023-08-14 |
SC 13G/A | 2023-07-10 |
4 | 2023-06-20 |
SC 13D/A | 2023-06-20 |
13F-HR | 2023-05-15 |
View Matrix Capital Management Company, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.